Juan Antonio Carrillo

Juan Antonio Carrillo

UNVERIFIED PROFILE

Are you Juan Antonio Carrillo?   Register this Author

Register author
Juan Antonio Carrillo

Juan Antonio Carrillo

Publications by authors named "Juan Antonio Carrillo"

Are you Juan Antonio Carrillo?   Register this Author

27Publications

254Reads

8Profile Views

N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.

Eur J Clin Pharmacol 2018 Jul 27;74(7):903-911. Epub 2018 Mar 27.

Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, Kragujevac, 34 000, Serbia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00228-018-2448-y
Publisher Site
http://dx.doi.org/10.1007/s00228-018-2448-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999125PMC
July 2018

Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients.

Br J Clin Pharmacol 2017 03 18;83(3):562-571. Epub 2016 Oct 18.

Department of Medical and Surgical Therapeutics, Division of Clinical Pharmacology, Medical School, University of Extremadura, Alcorcón, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.13130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306492PMC
March 2017

BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders.

Eur Child Adolesc Psychiatry 2014 Aug 29;23(8):669-79. Epub 2013 Nov 29.

Division of Clinical Pharmacology, Department of Medical and Surgical Therapeutics, Medical School, University of Extremadura, Avda. de Elvas s/n, 06005, Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00787-013-0495-6DOI Listing
August 2014

Comparisons of CYP2A6 genotype and enzyme activity between Swedes and Koreans.

Drug Metab Pharmacokinet 2013 24;28(2):93-7. Epub 2012 Jul 24.

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital-Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2133/dmpk.dmpk-12-rg-029DOI Listing
July 2014

High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population.

OMICS 2014 Jul 31;18(7):446-53. Epub 2013 Dec 31.

1 Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital , Karolinska Institutet, Stockholm, Sweden .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/omi.2013.0140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086241PMC
July 2014

Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features.

J Clin Psychopharmacol 2013 Aug;33(4):551-5

Department of Medical and Surgical Therapeutics, Division of Clinical Pharmacology, Medical School, University of Extremadura, Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0b013e3182970469DOI Listing
August 2013

Haplotypes in the 5'-untranslated region of the CYP1A2 gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism.

Environ Mol Mutagen 2013 Mar 9;54(2):124-32. Epub 2012 Nov 9.

Department of Medical & Surgical Therapeutics, Division of Pharmacology, Medical School, University of Extremadura, Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/em.21747DOI Listing
March 2013

Comparison of N-acetyltransferase-2 enzyme genotype-phenotype and xanthine oxidase enzyme activity between Swedes and Koreans.

J Clin Pharmacol 2012 Oct 21;52(10):1527-34. Epub 2011 Nov 21.

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital, Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270011420261DOI Listing
October 2012

N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.

J Clin Pharmacol 2011 Jul 27;51(7):994-1003. Epub 2010 Aug 27.

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270010377630DOI Listing
July 2011

GST polymorphisms interact with dietary factors to modulate lung cancer risk: study in a high-incidence area.

Nutr Cancer 2010 ;62(6):750-8

Department of Pharmacology, Medical School, University of Extremadura, Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581003605946DOI Listing
November 2010

Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.

Eur J Clin Pharmacol 2010 Aug 27;66(8):755-74. Epub 2010 Jun 27.

Department of Medical and Surgical Therapeutics, Division of Clinical Pharmacology, Medical School, University of Extremadura, 06071 Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-010-0857-7DOI Listing
August 2010

In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population.

Eur J Clin Pharmacol 2010 Jun 13;66(6):571-8. Epub 2010 Feb 13.

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, 14186, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-010-0785-6DOI Listing
June 2010

The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms and gender on the urinary excretion of the metabolites of the H-receptor antihistamine ebastine: a pilot study.

Br J Clin Pharmacol 2006 Aug;62(2):177-86

Department of Pharmacology and Psychiatry, Medical School and Clinical Pharmacology Unit, Infanta Cristina University Hospital, University of Extremadura, E-06071-Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2125.2006.02578.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885094PMC
August 2006

Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and Other Caucasian populations.

Ther Drug Monit 2005 Dec;27(6):819-21

Department of Pharmacology and Psychiatry, Medical School, and Clinical Pharmacology Unit, Infanta Cristina University Hospital, University of Extremadura, Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ftd.0000186914.32038.a0DOI Listing
December 2005

Evaluation of a drug-drug interaction alert structure through the retrospective analysis of statins-macrolides co-prescriptions.

Basic Clin Pharmacol Toxicol 2005 Apr;96(4):289-94

Drug Surveillance Center of Extremadura, Department of Pharmacology and Psychiatry & Clinical Pharmacology Unit, Infanta Cristina University Hospital, Medical School, University of Extremadura, Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1742-7843.2005.pto960403.xDOI Listing
April 2005

Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.

Clin Pharmacokinet 2004 ;43(11):693-706

Department of Pharmacology and Psychiatry, Medical School, University of Extremadura, Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003088-200443110-00001DOI Listing
September 2004

Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection.

Clin Chem 2003 Dec;49(12):2088-91

Department of Pharmacology and Psychiatry, Extremadura University School of Medicine, E-06071 Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2003.022517DOI Listing
December 2003

Xanthine oxidase activity is influenced by environmental factors in Ethiopians.

Eur J Clin Pharmacol 2003 Oct 21;59(7):533-6. Epub 2003 Aug 21.

Division of Molecular Toxicology, IMM, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-003-0653-8DOI Listing
October 2003

Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

Mol Pharmacol 2003 Sep;64(3):659-69

Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.64.3.659DOI Listing
September 2003

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.

J Clin Psychopharmacol 2003 Apr;23(2):119-27

Department of Pharmacology and Psychiatry, Extremadura University School of Medicine, Badajoz, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00004714-200304000-00003DOI Listing
April 2003

Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19).

Clin Pharmacol Ther 2002 Mar;71(3):141-52

Department of Medical Laboratory Sciences and Technology, Division of Clinical Pharmacology at Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/mcp.2002.121788DOI Listing
March 2002